Report : DNA Digital Data Storage Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Sequencing (Synthesis Sequencing, Ion Semiconductor Sequencing, Chain Termination Sequencing, Ligation Sequencing, and Nanopore Sequencing); Application (Diagnostic Research, Personalized Medicine, and Others); End User (Hospital and clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other), and Geography
According to our new research study on “DNA Digital Data Storage Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Sequencing, Application, and End User,” the market is expected to grow from US$ 57.81 million in 2021 to US$ 1,761.49 million by 2028, it is estimated to grow at a CAGR of 61.29% during 2021–2028. Factors driving the growth of the market are the presence of DNA digital data storage service providers and investments and innovation in DNA data storage.
Based on sequencing, the DNA digital data storage market is segmented synthesis sequencing, ion semiconductor sequencing, chain termination sequencing, ligation sequencing, and nanopore sequencing. The synthesis sequencing segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Sequencing by synthesis (SBS) technology utilizes four fluorescently labeled nucleotides to sequence the tens of millions of clusters on the flow cell surface in parallel. The market players are developing and offering solutions related to the segment which drives the segment growth.
The global economy was severely affected due to the COVID-19 cases in the region. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system. The outbreak is expected to leverage the technology adoption and usability to streamline the process during the COVID-19 treatment. The healthcare service providers and the patients are adopting and prefer remote treatment through telemedicine, tele health, and avoiding visiting hospitals to prevent the COVID19 infection in the hospitals and clinics. Moreover, the DNA data storage technology in under development and the use by the general population or organizations is limited. In addition the DNA data storage is comparatively costly to the traditional data storage methods. The components required and the supplies are as per demand. Thus, the COVID19 has a minimal impact on the DNA digital data storage market and expected to boost the market at positive rate in the coming years.
Illumina, Inc.; Twist Bioscience; Agilent Technologies, Inc.; Molecular Assemblies; Quantum Corporation; CATALOG; Microsoft Corporation; Iridia, Inc.; DNA Script; and Evonetix; are among the leading companies operating in the DNA Digital Data Storage market.
Based on sequencing, DNA digital data storage market is segmented into synthesis sequencing, ion semiconductor sequencing, chain termination sequencing, ligation sequencing, nanopore sequencing. Based on application the market is segmented into diagnostic research, personalized medicine, and others. Based on end user, the market is segmented into academics and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
Contact Person: Sameer Joshi
Email Id: email@example.com